Hemodynamic Disorders
By: Dr. SL Rasonable
outline
a. Edema and Effusions
b. Exudate vs. Transudate
c. Hyperemia and Congestion
d. Hemostasis, Hemorrhagic Disorders and Thrombosis
e. Embolisms
f. Infarction
g. Shock
Edema & Effusion
Edema & Effusion
• Hydrostatic Pressure
• Push water out
• Colloid Osmotic Pressure
• Pull water in
Edema & Effusion
• Edema
Accumulation of fluid in
Tissues
• Effusion
Fluid in Body Cavities
Types
• Due to elevated Hydrostatic Pressure • Inflammatory
or decreased Colloid Osmotic • Exudates
Pressure • Non-Inflammatory
• Transudates
Edema & Effusion
Causes:
• Increased Hydrostatic Pressure
• Focal Impairment in Venous Return
• Local: Deep Venous Thrombosis
• Generalized: Congestive Heart Failure
• Reduced Colloid Osmotic Pressure
• Decreased Albumin
• Nephrotic Syndrome
• Liver Disease
• Protein malnutrition
Edema & Effusion
Causes:
• Salt and Water Retention
• Both increased
Hydrostatic Pressure
and decreased Colloid
Osmotic Pressure
• Renal disorders
• hypoperfusion
Edema & Effusion
Causes:
• Lymphatic Obstruction
• Lymphedema
• Chronic Inflammation with Fibrosis
• Filariasis
• Mastectomy (Breast Removal)
Edema & Effusion
• Subcutaneous Edema • Pulmonary Edema
High hydrostatic pressure Lungs 2 to 3x the normal
Distribution is by gravity: weight
Frothy, blood tinged fluid
dependent Edema Left Ventricular Failure
Cardiac or Renal disease ARDS
• Periorbital
Edema Bacterial Infection
Edema of the eyelids • BrainEdema
Severe Renal Disease Localized or generalized
Narrowed sulci, distended gyri
Herniation leads to death
Hyperemia &
Congestion
Hyperemia & Congestion
• Both from increased Blood Volumes
• Hyperemia
Active process
Arteriolar dilatation leads to increased blood flow
Erythema: Increased Oxygenated Blood at the tissues
• Congestion
Passive process
Reduced blood flow from the tissues
Cardiac Failure – Systemic
Venous Obstruction – Localized
Hyperemia & Congestion
LUNGS
Acute Pulmonary Congestion
Engorged aveolar capillaries
Alveolar septal edema
Focal intraalveolar hemorrhage
Chronic Pulmonary Congestion
Thickened, fibrotic septa
Hemosiderin – laden macrophages
(heart failure cells)
Hyperemia & Congestion
LIVER
• Acute Hepatic Congestion
Distended central vein and
sinusoids
• Chronic Passive Congestion
Gross: Nutmeg Liver
Microscopic: centrilobular
hemorrhage, hemosiderin-laden
macrophages and hepatocyte
necrosis
Hemostasis,
Hemorrhagic Disorders
and Thrombosis
Hemostasis, Hemorrhagic Disorders and Thrombosis
• Hemostasis
process by which blood clots form at sites of vascular
injury
• Hemorrhagic Disorders
excessive bleeding
• Thrombotic Disorders
blood clots (often referred to as thrombi) form within intact
blood vessels or within the chambers of the heart
Hemostasis, Hemorrhagic Disorders and Thrombosis
ARTERIOLAR
VASOCONSTRICTION
• Markedly reduces blood
flow
• Reflex neurogenic
mechanisms
• Augmented by Endothelin
• Transient effect
Hemostasis, Hemorrhagic Disorders and Thrombosis
PRIMARY HEMOSTASIS
• Primary Hemostatic Plug/
Platelet Plug Formation
• von Willebrand Factor
(vWF) & collagen
• Platelet Adherence
• Platelet Activation
• Granule Release
• Recruitment
• Platelet Aggregation
Hemostasis, Hemorrhagic Disorders and Thrombosis
PLATELETS
• Alpha Granules:
• P-selectin, Fibrinogen,
Factor V, vWF, PF-4,
PDGF, TGF-B
• Dense Granules:
• ADP, ATP, iCa,
serotonin, epinephrine
Hemostasis, Hemorrhagic Disorders and Thrombosis
SECONDARY
HEMOSTASIS
Fibrin deposition
Hemostasis, Hemorrhagic Disorders and Thrombosis
SECONDARY HEMOSTASIS
Hemostasis, Hemorrhagic Disorders and Thrombosis
FIBRINOLYSIS
• Plasmin
• Breaks down fibrin and
interferes with
polymerization
Hemostasis, Hemorrhagic Disorders and Thrombosis
Hemostasis, Hemorrhagic Disorders and Thrombosis
• Platelet inhibitory effects
• Anticoagulant effects
• Thrombomodulin bind thrombin
• endothelial protein C receptor bind protein C
• vitamin K–dependent protease that requires a cofactor, protein S.
• Activated protein C/protein S complex is a potent inhibitor of
coagulation factors Va and VIIIa
• Heparin-like molecules
• Activate antithrombin
• Inhibit thrombin and IXa, Xa, XIa, XIIa
• Tissue Factor Pathway Inhibitor
• Inhibit VIIa
• Fibrinolytic Effects
THROMBOSIS
Hemostasis, Hemorrhagic Disorders and Thrombosis
ENDOTHELIAL INJURY
• Endothelial activation or
dysfunction
• Procoagulant changes
• Antifibrinolytic effects
Hemostasis, Hemorrhagic Disorders and Thrombosis
• Promote endothelial
activation, enhancing
ANORMAL BLOOD procoagulant activity and
leukocyte adhesion
FLOW • Disrupt laminar flow and
• Turbulence – arterial bring platelets into contact with
and cardiac thrombosis the endothelium
• Stasis – venous thrombi • Prevent washout and dilution
of activated clotting factors by
fresh flowing blood and the
inflow of clotting factor
inhibitors
Hemostasis, Hemorrhagic Disorders and Thrombosis
ANORMAL BLOOD FLOW
• Aneurysms – Aortic and arterial dilatations result
in local stasis
• Acute Myocardial Infarction – Cardiac mural
thrombi
• Rheumatic Mitral Valve Stenosis – Atrial dilation
and fibrillation
• Hyperviscosity – (Polycythemia vera), small
vessel stasis
• Sickle Cell Anemia – deformed RBCs impede
blood flow to small vesselsc
Hemostasis, Hemorrhagic Disorders and Thrombosis
HYPERCOAGULABILITY
Inherited
• Factor V Leiden mutation
Acquired
• Hyperestrogenic state
• Cancer
• Smoking
• Heparin Induced Thrombophilia
• Anti-Phospholipid Antibody Syndrome (APAS)
Hemostasis, Hemorrhagic Disorders and Thrombosis
• Morphology:
• Lines of Zahn
gross and microscopic laminations
Pale platelet and fibrin deposits alternating with darker red cell-rich
layers
• Mural Thrombi
Heart chambers and Aortic lumen
Arrythmias, DCM, MI, myocarditis
• Arterial Thrombi
Occlussive
Coronary, cerebral and femoral arteries
Friable network of platelets, fibrin, red cells and WBCs
Hemostasis, Hemorrhagic Disorders and Thrombosis
• Morphology:
• Venous Thrombi
Phlebothrombosis
Invariably occlusive forming a long luminal cast
Enmeshed red cells – red, or stasis thrombi
Firm, focally attached to the vessel wall and has lines of Zahn
Lower extremity vein
• Post Mortem Clots
Gelatinous, dark red dependent portion
Yellow (chicken fat) upper and red lower
Not attached to the vessel wall
Hemostasis, Hemorrhagic Disorders and Thrombosis
• Morphology:
• Vegetations
Thrombi in the heart valves
Fungi or bacteria
Infective endocarditis
Non bacterial thrombotic endocarditis
Sterile vegetations in persons with Hypercoagulable states
Libman-Sacks endocarditis
Sterile Verrucous
Systemic Lupus Erythematosus
Hemostasis, Hemorrhagic Disorders and Thrombosis
FATE OF THE THROMBUS
• Propagation
Accumulate additional platelets and fibrin
• Embolization
Thrombi dislodge and travel to other sites
• Dissolution
Result of Fibrinolysis
• Organization and Recanalization
Fibrous Lump after vessel wall changes
Hemostasis, Hemorrhagic Disorders and Thrombosis
• Thrombi come to clinical attention when they obstruct arteries or
veins, or give rise to emboli
• Venous Thrombosis (Phlebothrombosis)
Deep Venous Thrombosis (DVT)
Edema and pain
Embolize to the lungs
Hypercoagulability
Recent Surgery
Post Partum Pregnancy
• Arterialand Cardiac Thrombosis
Atherosclerosis
Loss of endothelial integrity with Abnormal Blood Flow
Hemostasis, Hemorrhagic Disorders and Thrombosis
• DISSEMINATED INTRAVASCULAR COAGULATION
(CONSUMPTION COAGULOPATHY)
Not a specific disease
Systemic activation of thrombin that lead to complicated
conditions
Organ Dysfunction
Microvascular thrombi: diffuse circulatory insufficiency
Activate fibrinolytic mechanisms
Shock
Embolism
Embolism
• An embolus is a detached intravascular solid, liquid, or
gaseous mass that is carried by the blood from its point
of origin to a distant site, where it often causes tissue
dysfunction or infarction
• Thromboembolism
Dislodged thrombi
Pulmonary Embolism
• From leg DVTs in 95% of cases
• Thrombifrom larger veins to the Right side of the heart then to the
Pulmonary arteries
• Saddle Embolus – pulmonary artery bifurcation
• Consequences:
Clinically Silent in 60 to 80%; organization
Sudden Death, Right Heart Failure (cor pulmonale) or CV collapse in
60% obstruction
Pulmonary Hemorrhage
Small end-arteriolar obstruction: Infarction and Hemorrhage
Multiple Emboli cause Pulmonary Hypertension and Right HF
Systemic Thromboembolism
• 80% from intracardiac mural thrombi
2/3 from LV wall infarct
¼ from LA dilation and fibrillation
• Others:aortic aneurysms, atherosclerotic plaques, valvular
vegetations or venous thrombi
• 10-15% unknown
• Endpoint:
75% lower extremities
10% brain
TISSUE INFARCTION
Fat and Marrow Embolism
• Fat
globules from bone marrow at
pulmonary vessels after LONG Fat Embolism Syndrome
BONE FRACTURE Pulmonary insufficiency
Neurologic Symptoms
• Trauma or Burns Anemia-thrombocytopenia
• 90% Dyspnea
in severe skeletal injuries
Tachycardia
• <10% have any clinical findings Coma after 1 to 3 days onset
of symptoms
Air Embolism
• Gas bubbles form frothy masses
Obstruct vessel flow
Distal Ischemic Injury
Bends: gas bubbles in muscles
• Surgical Complication or Chest Wall and joints
Injury Chokes: edema, hemorrhages,
• Air >100cc atelectasis or emphysema in
lungs
• Decompression Sickness
Sudden decreases in atmospheric
Caisson Disease
Chronic Form of
pressure
Scuba and deep sea divers Decompression Sickness
Amniotic Fluid Embolism
Symptoms
• Fifth most common cause of maternal • Sudden Severe
mortality Dyspnea
• Ominous complication of labor and • Cyanosis
immediate postpartum period • Shock
• Tear in the placental membrane or uterine • Neurologic
vein rupture impairment
• Findings: fetal skin, lanugo hair, fat from • Pulmonary Edema
vernix caseosa, muci • DIC
Infarction
An infarct is an area of ischemic necrosis caused by occlusion of either
the arterial supply or the venous drainage
Red Infarct
• Venous occlusions (testicular
torsion)
• Loose, spongy tissues
• Tissueswith dual circulations (lung,
small intestine)
• Tissuespreviously congested by
sluggish venous outflow
• Reestablished flow to a site of
arterial occlusion
White Infarct
• Arterialocclusions in solid
organs with end-arterial
circulation and tissue density
that limit blood seepage
Heart, Spleen and Kidney
Infarction
• Wedge-shaped
Apex-occluded vessel • Ischemic Coagulative Necrosis
Base-Organ periphery – dominant histologic
Serosal surface can have characteristic
fibrinous exudate • Septic Infarctions
• Infected cardiac valve
• Fresh infarcts are poorly
vegetations embolize or
defined but delineates microbes seed necrotic tissue
better over a few days • Converted into an abscess
Infarction
Factors
• Vascular Supply Anatomy
• Rateof Occlusion
Slow rate – less likely to cause infarction
• TissueVulnerability to Hypoxia
Neurons – 3 to 4 min
Myocardial cells – 20 to 30 min
Fibroblasts – hours
• Hypoxemia
Shock
Shock
•astate in which diminished cardiac output or
reduced effective circulating blood volume
impairs tissue perfusion and leads to cellular
hypoxia
Shock
Cardiogenic Shock
• Low cardiac output due to Myocardial pump
failure
• Intrinsic damage (MI)
• Extrinsic compression (Cardiac Tamponade)
• Ventricular arrythmias
• Outflow Obstruction (PE)
Hypovolemic Shock
• Low cardiac output due to low blood volume
• Massive hemorrhage
• Fluid loss from severe burns
Other Types
• Sepsis
- Systemic Inflammatory Response
Syndrome with a foci of Infection
• Septic Shock – with organ damage
Massive outpouring of Inflammatory mediators
• Neurogenic Shock – Spinal cord Injury
• AnaphylacticShock – IgE-mediated
hypersensitivity reaction
Septic Shock
• Inflammatory and Counter-inflammatory responses
• Endothelial activation and injury
• Induction of a procoagulant state
• Metabolic abnormalities
Hypergylcemia, Insulin resistance
Stressed-induced hormones
• Organ Dysfunction
Stages of Shock
••An initial nonprogressive phase during which reflex
compensatory mechanisms are activated and perfusion of vital
organs is maintained
•• A progressive stage characterized by tissue hypoperfusion
and onset of worsening circulatory and metabolic imbalances,
including lactic acidosis
••An irreversible stage that sets in after the body has incurred
cellular and tissue injury so severe that even if the
hemodynamic defects are corrected, survival is not possible
Shock
Shock
Reference: Kumar, Abbas, Ester. Robbins and Cotran
Pathologic Basis of Disease, 9th Ed. (2014)
THANK
YOU!